Summary
HPV Vaccine Singapore Clinic: HPV (human papillomavirus), cervical/penile/anal/mouth/throat cancer, genital warts vaccine Gardasil®/Cervarix® jab/shot/injection clinic, Singapore. - Definitions, references, and latest news.
Description
Table of Contents
HPV vaccine (previous known as cervical cancer vaccine) types: - Gardasil® [HPV (Human Papillomavirus) Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant]
- Cervarix® [HPV (Human Papillomavirus) Bivalent (Types 16 and 18) Vaccine, Recombinant]
- nine-valent [HPV (Human Papillomavirus) Nonavalent (Types 6, 11, 16, 18, 31, 33, 45, 52, and 58) Vaccine, Recombinant] - to be released in 2013
Gardasil® [HPV (Human Papillomavirus) Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] Cervarix® [HPV (Human Papillomavirus) Bivalent (Types 16 and 18) Vaccine, Recombinant] Human papillomavirus (HPV) There are nearly 200 known types of HPV. They cause Major types: HPV Type | Disease | Cervarix® Vaccine | Gardasil® Vaccine | nonavalent Vaccine | Digene® Test |
| 6 | Genital warts | | × | × | |
| 11 | Genital warts | | × | × | |
| 16 | High risk | × | × | × | × |
| 18 | High risk | × | × | × | × |
| 31 | High risk | | | × | × |
| 33 | High risk | | | × | × |
| 35 | High risk | | | | × |
| 39 | High risk | | | | × |
| 45 | High risk | | | × | × |
| 51 | High risk | | | | × |
| 52 | High risk | | | × | × |
| 56 | High risk | | | | × |
| 58 | High risk | | | × | × |
| 59 | High risk | | | | × |
| 68 | High risk | | | | × |
Genital warts is also known as condyloma, condylomata acuminata, venereal wart, anal wart, anogenital wart, and "cauliflower" sex disease.
Genital warts appear within 3 months after sexual contact with an infected person.
Genital warts:
- are usually soft, pink cauliflower-like growths or flesh-coloured bumps on the sex organs
- may also be hard and smooth
- occur alone or in groups
- tend to recur after treatment
- increase the risk of cervical cancer in women.
An infected woman may infect her newborn during childbirth. A person with genital warts can infect others through sexual contact.
The majority of genital warts is caused by the human papillomavirus (HPV) types 6 and 11. It is usually treated by cryosurgery with liquid nitrogen. Prevention is possible with a HPV vaccine like Gardasil®.
HPV test for men/women. Cost is SG$200/= for the Digene® HPV test. It tells you and your healthcare provider whether you have one or more of the 13 most important high-risk types of the virus: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and 68.
References
Latest News
An HPV vaccine cheap enough for the developing world? Could be
Thu, 29 Jul 2010 07:42:52 +0100 | ScienceDaily Headlines
Vaccine manufacturers in India and other developing countries may be able to produce a lower-cost HPV vaccine in spite of the complicated array of patent protections on the technology, say researchers. (Source: ScienceDaily Headlines)
Experts Concerned About Increase In HPV-Related Head And Neck Cancers
Wed, 28 Jul 2010 10:00:00 +0100 | Health News from Medical News Today
The human papillomavirus increasingly is being identified as the cause of head and neck cancers, prompting some physicians to guess that the genesis of the cancers might be oral sex, the Raleigh News & Observer reports. David Brizel, an oncologist at Duke University who specializes in head and neck cancers, said, "A third of head and neck cancers we see nowadays are [related to] HPV." Although few studies have established a direct link between oral sex, through which HPV can be transmitted, and head and neck cancers, recent studies published in both European and U.S... (Source: Health News from Medical News Today)
Zetiq Reports CE Conformity For Its Cervical Cancer Diagnostic Kit
Wed, 28 Jul 2010 08:00:00 +0100 | Health News from Medical News Today
Zetiq Technologies Ltd. ("Zetiq"), a subsidiary of Bio-Light Ltd. (TASE: BOLT), reports that it has fulfilled the essential requirements towards issuing a self declaration CE mark of conformity for its diagnostic product for identification of cervical cancer in cytological specimens. The requirements fulfilled by the company comply with Council Directive 98/79/EEC for in vitro diagnostic medical devices. As part of these requirements, the Zetiq laboratory has recently received an ISO 13485: 2003 certificate for developing and manufacturing medical products... (Source: Health News from Medical News Today)
Einstein Receives $4 Million To Test HPV Microbicide
Sun, 25 Jul 2010 08:00:00 +0100 | Health News from Medical News Today
The National Cancer Institute has awarded Albert Einstein College of Medicine of Yeshiva University $4.1 million to test the microbicide Carraguard® against the human papillomavirus (HPV), which causes cervical cancer. The research will evaluate the efficacy of Carraguard®, a clear gel made from the seaweed derivative carrageenan in preventing new HPV infections in women. According to the World Health Organization, approximately 440 million males and females are infected with HPV worldwide. The Centers for Disease Control estimates at least 20 million Americans have HPV... (Source: Health News from Medical News Today)
Should men be getting the HPV vaccine too?
Sat, 24 Jul 2010 11:28:31 +0100 | CTV Health
HPV, known for causing cervical cancer, is emerging as the leading cause of throat cancer in men. Should they get the vaccine too? Read about it on CTV.ca (Source: CTV Health)
Quadrivalent HPV Vaccine Safe and Effective in Men
Fri, 23 Jul 2010 17:34:13 +0100 | Medscape Dermatology Headlines
The quadrivalent human papillomavirus (HPV) vaccine (Gardasil) prevents infection and disease in men, according to data presented today at ---- 2010 in Vienna. Reuters Health Information (Source: Medscape Dermatology Headlines)
IAC: HPV Vaccine Effective in Men (CME/CE)
Fri, 23 Jul 2010 14:13:20 +0100 | MedPage Today State Required CME
VIENNA (MedPage Today) -- A quadrivalent vaccine against four strains of human papillomavirus was highly effective at reducing external genital lesions in men, a researcher said here. (Source: MedPage Today State Required CME)
Cheap HPV vaccines 'possible without violating patent laws'
Fri, 23 Jul 2010 09:00:05 +0100 | SciDev.Net
Costly cervical cancer vaccines do not cover all HPV strains in poorer countries, potentially opening the market to other products. (Source: SciDev.Net)
Vaccination with alternative HPV jab offers 'strong' defence against genital warts
Fri, 23 Jul 2010 00:00:00 +0100 | Nursing Times Breaking News
Human papillomavirus immunisation with one of the vaccines available can give “strong and sustained” protection against genital warts and pre-cancerous growths of the cervix, international research has found. (Source: Nursing Times Breaking News)